Epstein–Barr virus (EBV)-infected cells are known to have increased PD-L1 expression, suggesting EBV-driven lymphomas may be specifically vulnerable to PD-1/PD-L1 blockade [3, 4]. The gene discussed is CD274; the disease is lymphoma.